Literature DB >> 3054805

The packing of acetylcholine into quanta at the frog neuromuscular junction is inhibited by increases in intracellular sodium.

W Van der Kloot1.   

Abstract

Pretreatment with hypertonic solutions, insulin, or adrenaline increases the size of quanta at the frog neuromuscular junction, as determined by measurements of miniature end plate potentials or currents (Van der Kloot and Van der Kloot 1985, 1986). The increase in quantal size apparently is due to an increase in acetylcholine (ACh) content of individual quanta. These treatments, therefore, can be used to study the packaging of ACh. Previously, I reported that increases are blocked by an inhibitor of active ACh uptake into vesicles (Van der Kloot 1986b, 1987b). The present study shows that the increases in quantal size were antagonized by inhibiting the Na+-K+ exchange pump with 100 microM ouabain, 10 microM dihydroouabain, or K+-free solutions. The increases in quantal size were also antagonized by 10 microM monensin, a Na+ ionophore, or by 5 microM aconitine, which opens Na+ channels at normal resting potentials. Apparently a rise in intracellular [Na+] inhibits the addition of ACh to quanta. The mechanism by which a rise in intracellular Na+ inhibits ACh packing is unknown, but apparently it is not due to inhibition of choline reuptake into the terminals. Also consistent with the above hypothesis is that the increase in quantal size following depolarization for 2 h in elevated [K+]out was substantially enhanced when tetrodotoxin (TTX) was present, suggesting that in the absence of TTX there is a rise in [Na+]in that antagonizes the incorporation of additional ACh into the quanta.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3054805     DOI: 10.1007/bf00582506

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  33 in total

1.  On the factors which determine the amplitude of the miniature end-plate potential.

Authors:  B KATZ; S THESLEFF
Journal:  J Physiol       Date:  1957-07-11       Impact factor: 5.182

2.  Spontaneous subthreshold activity at motor nerve endings.

Authors:  P FATT; B KATZ
Journal:  J Physiol       Date:  1952-05       Impact factor: 5.182

3.  The action of sodium pump inhibitors on neuromuscular transmission.

Authors:  R I Birks; M W Cohen
Journal:  Proc R Soc Lond B Biol Sci       Date:  1968-07-09

4.  Activity increases quantal size at the frog neuromuscular junction.

Authors:  W Van der Kloot; T E Van der Kloot
Journal:  Experientia       Date:  1985-01-15

5.  Temperature effects on spontaneous and evoked quantal size at the frog neuromuscular junction.

Authors:  W Van der Kloot; I S Cohen
Journal:  J Neurosci       Date:  1984-09       Impact factor: 6.167

6.  Evidence that an ATPase and a protonmotive force function in the transport of acetylcholine into storage vesicles.

Authors:  L Toll; B D Howard
Journal:  J Biol Chem       Date:  1980-03-10       Impact factor: 5.157

7.  Pretreatment with hypertonic solutions increases quantal size at the frog neuromuscular junction.

Authors:  W Van der Kloot
Journal:  J Neurophysiol       Date:  1987-05       Impact factor: 2.714

8.  Changes in total and quantal release of acetylcholine in the mouse diaphragm during activation and inhibition of membrane ATPase.

Authors:  E S Vizi; F Vyskocil
Journal:  J Physiol       Date:  1979-01       Impact factor: 5.182

9.  Long-term potentiation of transmitter release induced by repetitive presynaptic activities in bull-frog sympathetic ganglia.

Authors:  K Koyano; K Kuba; S Minota
Journal:  J Physiol       Date:  1985-02       Impact factor: 5.182

10.  Choline: high-affinity uptake by rat brain synaptosomes.

Authors:  H I Yamamura; S H Snyder
Journal:  Science       Date:  1972-11-10       Impact factor: 47.728

View more
  1 in total

1.  Calcitonin gene-related peptide acts presynaptically to increase quantal size and output at frog neuromuscular junctions.

Authors:  W Van der Kloot; W B Benjamin; O P Balezina
Journal:  J Physiol       Date:  1998-03-15       Impact factor: 5.182

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.